Dr. Pinchas Cohen, MD
USC Leonard Davis School
Biography & Research Background
Pinchas Cohen, MD, is Dean of the USC Leonard Davis School of Gerontology and co-founder of CohBar, Inc. He led the initial discovery and characterization of MOTS-c, identifying its role in regulating metabolic homeostasis, insulin sensitivity, and preventing diet-induced obesity. His lab has overseen research into the peptide's applications for age-related diseases including diabetes, cardiovascular disease, and longevity. Key publications: 'The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance' (2015, Cell Metabolism) and 'MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline' (2021, Nature Communications). Pinchas Cohen is referenced as a foundational scientist in MOTS-c research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Pinchas Cohen, MD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Pinchas Cohen, MD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.
